The KBMO Gut Barrier Panel (GBP) is a premier diagnostic tool designed to provide a comprehensive assessment of intestinal permeability, commonly known as leaky gut. By measuring eight advanced gatekeeper markers—including Candida, Zonulin, Occludin, and Lipopolysaccharides (LPS)—this panel identifies gut dysfunction ranging from mild sensitivity to severe barrier breakdown. Utilizing a dual-pathway approach with IgG 1–4/C3d and IgA 1–2, the GB Panel offers a highly accurate evaluation of the immune system's response to gut-related stressors. Available as a convenient fingerstick test or included with FIT 132 and FIT 176 screenings, it provides clinicians and patients with the actionable data needed to restore gut integrity and improve overall systemic health. Recommended use: As directed by your healthcare professional based on individual diagnostic needs. This information is provided as a medical and scientific educational resource for licensed health‑care practitioners and not intended for use by consumers for medical treatments of illness or disease. All recommendations regarding protocols, dosing, prescribing, and/or usage instructions should be tailored to the individual needs of the patient considering their medical history and provided by their treatment practitioner. Any information contained within should not be constructed as healthcare claims nor should it be used as a suggested guideline. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
